These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20681439)

  • 1. Transferring behavioral interventions for global health: intellectual property barriers, information constraints, and possible solutions.
    Underhill K
    Yale J Health Policy Law Ethics; 2010; 10(2):357-98. PubMed ID: 20681439
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurological disease on the global agenda.
    Johnston SC; Hauser SL
    Ann Neurol; 2008 Jul; 64(1):A11-2. PubMed ID: 18668532
    [No Abstract]   [Full Text] [Related]  

  • 3. [Industry and pharmaceutical research in Italy. How to make up for lost time].
    Mortari U
    Recenti Prog Med; 2006 Nov; 97(11):634-9. PubMed ID: 17252720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
    Cohen-Kohler JC; Forman L; Lipkus N
    Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global player in cancer research: IARC celebrates its 40th anniversary.
    Steimle S
    J Natl Cancer Inst; 2005 Oct; 97(19):1400-1. PubMed ID: 16204686
    [No Abstract]   [Full Text] [Related]  

  • 6. Who shall live when not all can live? Intellectual property in accessing and benefit-sharing influenza viruses through the World Health Organisation.
    Lawson C
    J Law Med; 2011 Mar; 18(3):554-76. PubMed ID: 21528740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [International health research: priorities and commitment].
    Kruse AY; Bygbjerg IC
    Ugeskr Laeger; 2006 Sep; 168(36):2996-8. PubMed ID: 16999885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of physical activity evidence, programs, policies, and surveillance in the international public health arena.
    Bauman AE; Nelson DE; Pratt M; Matsudo V; Schoeppe S
    Am J Prev Med; 2006 Oct; 31(4 Suppl):S57-65. PubMed ID: 16979470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intellectual property. University licensing and the Bayh-Dole Act.
    Thursby JG; Thursby MC
    Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
    [No Abstract]   [Full Text] [Related]  

  • 10. Global trade and health: key linkages and future challenges.
    Bettcher DW; Yach D; Guindon GE
    Bull World Health Organ; 2000; 78(4):521-34. PubMed ID: 10885181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges for intellectual property management of HIV vaccine-related research and development: part 1, the global context.
    Knowles L; Bubela T
    Health Law J; 2008; 16():55-95. PubMed ID: 19536978
    [No Abstract]   [Full Text] [Related]  

  • 12. Production and consumption of science in a global context.
    Mancia JR; Gastaldo D
    Nurs Inq; 2004 Jun; 11(2):65-6. PubMed ID: 15154884
    [No Abstract]   [Full Text] [Related]  

  • 13. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
    Rovira J
    Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
    [No Abstract]   [Full Text] [Related]  

  • 14. Openness is key in fight against disease outbreaks.
    Burns W
    Bull World Health Organ; 2006 Oct; 84(10):769-70. PubMed ID: 17128351
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicine. The need for a global HIV vaccine enterprise.
    Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN
    Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inequalities of access to care and in participation in research on a worldwide level: ethical problems].
    France. Comite consultatif national d'ethique pour les sciences de la vie et de la sante
    J Int Bioethique; 2005; 16(3-4):152-3. PubMed ID: 17058809
    [No Abstract]   [Full Text] [Related]  

  • 17. Reducing the worldwide burden of cancer.
    Markman M
    Oncology; 2007; 73(1-2):1. PubMed ID: 18332647
    [No Abstract]   [Full Text] [Related]  

  • 18. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empowering the inventor--the case of monoclonal antibodies.
    Clark M
    Nat Biotechnol; 2005 Sep; 23(9):1047-9. PubMed ID: 16151388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons from SARS.
    Bloom BR
    Science; 2003 May; 300(5620):701. PubMed ID: 12730561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.